畜牧兽医学报 ›› 2024, Vol. 55 ›› Issue (12): 5774-5783.doi: 10.11843/j.issn.0366-6964.2024.12.039

• 基础兽医 • 上一篇    下一篇

绵羊痒螨重组丝氨酸蛋白酶抑制剂对小鼠银屑病样皮肤炎症的影响

田焱(), 杨富升, 李艳娥, 梁友萍, 樊洁, 吴芳燕, 古小彬*()   

  1. 四川农业大学动物医学院, 成都 611130
  • 收稿日期:2024-02-02 出版日期:2024-12-23 发布日期:2024-12-27
  • 通讯作者: 古小彬 E-mail:2021203026@stu.sicau.edu.cn;guxiaobin198225@126.com
  • 作者简介:田焱(1999-), 女, 彝族, 四川乐山人, 硕士生, 主要从事动物寄生虫病学研究, E-mail: 2021203026@stu.sicau.edu.cn
  • 基金资助:
    四川省科技计划重点研发项目(2019YFN0155);四川农业大学学科双支计划(2221993268)

Effect of Recombinant Serpins of Psoroptes ovis on Psoriasis-like Skin Inflammation in Mice

TIAN Yan(), YANG Fusheng, LI Yan'e, LIANG Youping, FAN Jie, WU Fangyan, GU Xiaobin*()   

  1. College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China
  • Received:2024-02-02 Online:2024-12-23 Published:2024-12-27
  • Contact: GU Xiaobin E-mail:2021203026@stu.sicau.edu.cn;guxiaobin198225@126.com

摘要:

课题组前期发现绵羊痒螨的重组丝氨酸蛋白酶抑制剂4和5(recombinant serine protease inhibitors 4 and 5, rPsoSP4和rPsoSP5)可体外抑制糜蛋白酶、胰蛋白酶和弹性蛋白酶的活性,因此推测其可能具有抗炎活性,为证实上述推测,评价了rPsoSP4和rPsoSP5是否可以改善小鼠银屑病样皮肤炎症。BALB/c小鼠随机分为5组,用凡士林或咪喹莫特乳膏(imiquimod cream, IMQ)连续涂抹背部皮肤6 d, 建立空白对照组和银屑病模型,期间模型组每日皮内注射PBS(IMQ组)或pET32a(+)载体蛋白(IMQ+pET32a(+)组)或rPsoSP4(IMQ+rPsoSP4组)或rPsoSP5(IMQ+rPsoSP5组),每天观察小鼠银屑病样皮损区变化,于第7天处死小鼠,比较各组皮损组织病理变化和皮损组织中IL-1β、IL-6和TNF-α的转录水平。结果表明:IMQ造模成功,小鼠呈现典型的银屑病样皮损;与模型组(IMQ组)相比,IMQ+rPsoSP4组可有效改善小鼠银屑病样皮损,包括显著抑制小鼠体重减轻(第4~6天,P < 0.05,P < 0.01,P < 0.001)和皮损区红斑(第5~6天)、鳞屑(第4~6天)、皮肤增厚程度(第4~6天)及PASI评分(第3~6天)显著减少(P < 0.05,P < 0.001)。此外,与IMQ组相比,IMQ+rPsoSP4组皮损区组织病理损伤显著减轻,表皮厚度显著降低(P < 0.05),浸润的炎性细胞数量极显著减少(P < 0.001),皮损区IL-1β、IL-6和TNF-α mRNA水平极显著降低(P < 0.001,P < 0.000 1),而IMQ+rPsoSP5组对小鼠银屑病样皮损无明显改善。综上,rPsoSP4可显著改善小鼠银屑病样皮损,具有显著的抗炎活性,而rPsoSP5的抗炎活性不明显。

关键词: 绵羊痒螨, rPsoSP4, rPsoSP5, 银屑病样皮肤炎症, 抗炎活性

Abstract:

Our team previously found that recombinant serine protease inhibitors 4 and 5 (rPsoSP4 and rPsoSP5) of Psoroptes ovis could inhibit the enzymatic activities of chymotrypsin, trypsin and elastase in vitro, thus we speculated that these two recombinant proteins might have anti-inflammation activities. To confirm the above speculation, we assessed whether rPsoSP4 and rPsoSP5 could improve psoriatic-like skin inflammation in mice. BALB/c mice were randomly divided into 5 groups (n=6), Vaseline or imiquimod cream (IMQ) was applied daily on the back skin continuously for 6 days to establish the control group and psoriasis model groups. During this period, the psoriasis model groups were intradermal injected with PBS (IMQ group) or pET32a(+)-vector protein (IMQ+pET32a(+) group) or rPsoSP4 (IMQ+rPsoSP4 group) or rPsoSP5(IMQ+rPsoSP5 group), then the changes of psoriasis-like skin lesions were observed every day, and mice were sacrificed on the 7th day. Subsequently, the pathological changes and the transcription levels of IL-1β, IL-6, and TNF-α in the skin lesions among each group were compared. Results showed that IMQ induced psoriasis-like lesions were successfully established, and the mice appeared typical psoriasis-like lesions. Compared with the model group (IMQ group), IMQ+rPsoSP4 group can effectively attenuated psoriasis-like skin lesions, including significant inhibition of weight loss (from 4th to 6th day, P < 0.05, P < 0.01, P < 0.001) and reductions of skin erythema (5th and 6th day), skin scales (from 4th to 6th day), skin thickness (from 4th to 6th day) and PASI score (from 3rd to 6th day) in mice (P < 0.05, P < 0.001). Additionally, compared with the model group (IMQ group), IMQ+rPsoSP4 group showed that the pathological damage in the skin lesion was significantly reduced, accompanied by the significant decrease in epidermal thickness (P < 0.05) and the number of infiltrated inflammatory cells (P < 0.001). Moreover, there was a significantly decreased in mRNA levels of IL-1β, IL-6, and TNF-α in the skin lesion of IMQ+rPsoSP4 group in comparison with IMQ groups, while IMQ+rPsoSP5 group had no significant improvement on psoriatic lesions. In conclusion, rPsoSP4 could significantly improve psoriasis skin lesion in mice and has significant anti-inflammatory activity, while rPsoSP5 seemed to be no obvious effect.

Key words: Psoroptes ovis, rPsoSP4, rPsoSP5, psoriasis-like skin inflammation, anti-inflammatory activity

中图分类号: